Despite affecting 1 in 20 people who menstruate, Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME), remain widely misunderstood, underdiagnosed, and dismissed. For those living with these conditions, the impact is far more severe than typical premenstrual discomfort—it can be life-altering and even life-threatening.
PMDD is a severe, hormone-related mood disorder that causes debilitating emotional and physical symptoms in the luteal phase (the one to two weeks before menstruation). PME, on the other hand, worsens pre-existing conditions such as depression, anxiety, bipolar disorder, ADHD, PTSD, and chronic pain disorders during the same phase of the cycle.
“The consequences are severe! People with PMDD face a significantly higher risk of suicide. Research shows that up to 34% of people with PMDD have attempted suicide, and they are twice as likely to die by suicide as their unaffected peers. Many individuals struggle for years without a diagnosis, often being told it’s “just hormones“ or “just your period,” while their symptoms severely impact their lives. Patients are forced to navigate a frustrating process of trial and error with antidepressants, hormonal therapies, or even surgical menopause to manage symptoms. The message is clear: Silence is no longer an option,” says Sandi MacDonald, co-founder of the International Association for Premenstrual Disorders (IAPMD). “How many people have to suffer before PMDs are taken seriously?”
April is Premenstrual Disorders (PMD) Awareness Month, and IAPMD is leading a global campaign to demand greater recognition, research, and support for those affected. Through personal stories, advocacy, and education, IAPMD aims to shift the conversation from dismissal to action. “Too many people are suffering in silence, feeling unheard and alone,” says MacDonald. “No one should have to fight this battle without support. That’s why we’re amplifying real voices and pushing for real change.”
IAPMD is calling for:
- Increased research funding to develop better treatments and a deeper understanding of the neurobiological and hormonal mechanisms behind PMDD and PME.
- Better medical training to ensure earlier and more accurate diagnoses, reducing the 12-year average delay in getting proper treatment.
- Stronger workplace and educational accommodations so individuals affected by PMDs can receive the support they need to function and thrive.
Join the movement this April and help break the silence. Follow @iapmdglobal on social media for awareness campaigns. Use the hashtags #PMDAwarenessMonth2025 #PMDStrongerTogether to spread awareness. Visit iapmd.org for resources, peer support, and advocacy opportunities.
“Awareness saves lives,” MacDonald emphasizes. “Together, we can ensure that PMDD and PME are taken seriously. Together, we are stronger.”
Media Contact:
Sandi MacDonald
Email: sandi@iapmd.org
Discover more about International Association for Premenstrual Disorders:
The International Association for Premenstrual Disorders (IAPMD) is a global nonprofit dedicated to supporting, educating, and advocating for those affected by Premenstrual Disorders. Through peer support, evidence-based resources, research initiatives, and policy advocacy, IAPMD works to improve diagnosis, treatment, and overall quality of life for individuals living with these debilitating conditions. Committed to breaking the stigma surrounding hormone-related mood disorders, IAPMD strives to ensure that no one suffers alone and that every person has access to the care and understanding they deserve. Learn more at iapmd.org.
